Evidence map›Paper›PMID 30108374›Full record

SynthesisProstate cancer and prostatic diseases2018

Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies.

Zhenlang Guo, Shu Gan, Yuan Li, Chiming Gu, Songtao Xiang, Jianfu Zhou, Leiliang Gong, Franky Leung Chan, Shusheng Wang

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Prostate cancer and prostatic diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Living with prostate cancer: a mixed-method evaluation of group therapy intervention to alleviate psychological distress in a Canadian setting.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zhenlang GuoThe Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
Shu GanDepartment of Urology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Yuan LiDepartment of Urology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Chiming GuDepartment of Urology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Songtao XiangDepartment of Urology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Jianfu ZhouDepartment of Urology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Leiliang GongDepartment of Mechanical Engineering, National University of Singapore, Kent Ridge, Singapore, Singapore.
Franky Leung ChanSchool of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Shusheng WangDepartment of Urology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China. shushengwanggzy@163.com.
Chinese University of Hong Kong · CNGuangzhou University of Chinese Medicine · CNNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhether the diagnosis of prostate cancer is a contributory psychological stress that causes excess risk of suicide among affected men remains controversial. We performed a meta-analysis of previous studies to investigate suicide incidence and associated risk factors among men diagnosed with prostate cancer.

methodsThe MEDLINE, Embase, Cochrane Library, and PsycINFO databases were searched to identify eligible studies published before April 2018. The inverse variance method with random-effects modeling was used to calculate summary relative risks (RRs) and their associated 95% confidence intervals (CIs).

resultsEight observational studies involving 1,281,393 men diagnosed with prostate cancer and 842,294 matched prostate cancer-free men were included. An overall increased RR of suicide of 2.01 (95% CI: 1.52-2.64; P < 0.001; I

conclusionsCurrent evidence indicates that the risk of suicide is increased among men diagnosed with prostate cancer, particularly those aged 75 years or older, <12 months after diagnosis, and treated with hormonal therapy. Healthcare providers should be aware of these special populations considered at high risk of suicide. Hence, further research should be conducted to refine suicide risk assessment with detection tools and to develop the best practices for prevention.

Indexed as

Follow-Up StudiesHumansIncidenceMaleOdds RatioProstatic NeoplasmsRisk AssessmentRisk FactorsSocioeconomic FactorsSuicide

Identifiers

PMID30108374
OpenAlexW2885901037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.